Free Trial

Bank of New York Mellon Corp Sells 6,920 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy logo with Medical background

Bank of New York Mellon Corp lessened its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.2% in the first quarter, according to its most recent filing with the SEC. The fund owned 125,366 shares of the company's stock after selling 6,920 shares during the period. Bank of New York Mellon Corp owned about 0.83% of U.S. Physical Therapy worth $9,071,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its holdings in shares of U.S. Physical Therapy by 27,856.8% in the first quarter. GAMMA Investing LLC now owns 12,301 shares of the company's stock valued at $890,000 after purchasing an additional 12,257 shares in the last quarter. Lazard Asset Management LLC acquired a new position in U.S. Physical Therapy during the fourth quarter valued at approximately $84,000. Wells Fargo & Company MN raised its stake in shares of U.S. Physical Therapy by 2.2% during the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after acquiring an additional 2,465 shares during the last quarter. Deutsche Bank AG increased its position in shares of U.S. Physical Therapy by 49.3% during the fourth quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock worth $1,169,000 after buying an additional 4,350 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in shares of U.S. Physical Therapy by 2.3% in the first quarter. Principal Financial Group Inc. now owns 84,964 shares of the company's stock valued at $6,148,000 after buying an additional 1,873 shares in the last quarter.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director owned 2,594 shares of the company's stock, valued at $202,357.94. This trade represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 2.00% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. JMP Securities reiterated a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research reiterated an "outperform" rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $109.00.

Check Out Our Latest Stock Analysis on USPH

U.S. Physical Therapy Stock Up 0.3%

Shares of NYSE USPH traded up $0.21 during mid-day trading on Tuesday, hitting $75.15. The company had a trading volume of 172,920 shares, compared to its average volume of 125,534. The firm has a 50-day simple moving average of $76.84 and a two-hundred day simple moving average of $78.39. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.14 billion, a PE ratio of 34.47, a price-to-earnings-growth ratio of 3.59 and a beta of 1.44. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. U.S. Physical Therapy's revenue for the quarter was up 18.0% on a year-over-year basis. During the same period last year, the firm earned $0.51 EPS. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.40%. The ex-dividend date of this dividend was Friday, May 23rd. U.S. Physical Therapy's payout ratio is 82.57%.

About U.S. Physical Therapy

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines